PRAX: Wutah pendapatan triwulanan Praxis Medicines

Logo korporat perusahaan Praxis Precision Medicines, Inc. (PRAX)

Praxis Precision Medicines developments are protected by stringent FDA requirements and small molecule patents. Stable demand is driven by the creation of therapies for the treatment of chronic CNS disorders. Global expansion potential is based on the ownership of unique intellectual property. The percentage change in quarterly revenue reflects the dynamics of these processes, where 0.00 characterizes this business efficiency metric.

PRAX (Praxis Precision Medicines Inc) riwayat Wutah dodolan triwulanan saka 04.07.2022 nganti 20.11.2026

Rincian metrik lan analitis perusahaan Praxis Precision Medicines, Inc. (PRAX)

- kuotasi saiki lan rata-rata prakiraan nilai:
- indikator dhuwit lan ilining kas:
Analisis fundamental perusahaan:PRAX - Praxis Precision Medicines Inc
Produk seri praxismedicines.com

Praxis Precision Medicines' development of CNS therapies creates long-term demand, although the current stage of commercialization requires strict monitoring of cash flow dynamics. By analyzing the quarter-over-quarter revenue growth rate, which currently stands at 0.00, investors can track the percentage change in sales on a daily basis, allowing for the rapid identification of any fading fundamental drivers prior to the release of official financial reports.

Pesaing utama

BIIB - Wutah pendapatan kuartal marang kuartal|NBIX (Neurocrine Biosciences) - Wutah dodolan kuartal marang kuartal|RGC: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Axsome (AXSM)|Wutah pendapatan kuartal marang kuartal ACADIA Pharmaceuticals Inc|Wutah dodolan triwulanan Xenon Pharmaceuticals Inc (XENE)|Wutah pendapatan triwulanan VKTX|Wutah pendapatan triwulanan supernus.com (SUPN)|Wutah pendapatan kuartal marang kuartal Catalyst Pharmaceuticals, Inc. CPRX|DNLI (Denali Therapeutics Inc.) - Dinamika pendapatan kuartal marang kuartal|Harmony Corp - Wutah pendapatan triwulanan|BHVN: Wutah pendapatan kuartal marang kuartal|AMLX: Wutah pendapatan triwulanan|TRVI: Owah-owahan dodolan kuartal marang kuartal|AVXL (Anavex Life Sciences Corp) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal CBLL|Wutah dodolan triwulanan PRTA (prothena.com)|Alector - Wutah dodolan kuartal marang kuartal|Wutah pendapatan triwulanan ANNX (Annexon Biosciences)|OMER: Wutah dodolan kuartal marang kuartal|NGNE - Wutah pendapatan kuartal marang kuartal|ACIU - Wutah pendapatan triwulanan|Voyager Corp (VYGR) - Wutah pendapatan kuartal marang kuartal|NMRA - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Scilex|TVGN (Tevogen Bio) - Owah-owahan dodolan kuartal marang kuartal|Wutah dodolan triwulanan ACOG (alphacognition.com)|Tingkat wutah dodolan sajrone kuartal Cognition Therapeutics, Inc.|Wutah pendapatan triwulanan IKT (Inhibikase Pharma)|Wutah pendapatan triwulanan Cassava Sciences, Inc. SAVA|ASRT - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Coya Therapeutics Inc|Vistagen Therapeutics (VTGN) - Wutah pendapatan kuartal marang kuartal|OVID - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Acumen Pharmaceuticals, Inc|Wutah pendapatan kuartal marang kuartal CRVO|Wutah pendapatan triwulanan ATHE|Clene - Wutah dodolan kuartal marang kuartal|Wutah pendapatan triwulanan PEPG (pepgen.com)|JUNS: Wutah dodolan kuartal marang kuartal|RLMD - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Annovis Bio, Inc.|GRCE (Grace Therapeutics) - Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Firefly Neuroscience (AIFF)|Wutah dodolan triwulanan KLTO|NRSN: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Reviva Pharmaceuticals Holdings (RVPH)|Wutah dodolan triwulanan MetaVia, Inc. MTVA|Wutah pendapatan kuartal marang kuartal NeurAxis NRXS|HSDT: Wutah dodolan kuartal marang kuartal|passagebio.com - Wutah pendapatan triwulanan|NEUP - Wutah pendapatan triwulanan|Minerva Neurosciences Corp (NERV) - Wutah pendapatan kuartal marang kuartal|Dinamika pendapatan kuartal marang kuartal ATHA (Athira)|ADXN (Addex Therapeutics Ltd.) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal ALZN (Alzamend Neuro)|Wutah pendapatan kuartal marang kuartal Cyclerion Therapeutics Inc. (CYCN)|Wutah pendapatan triwulanan Protagenic Therapeutics, Inc. (PTIX)|Wutah pendapatan triwulanan KTTA (Pasithea Therapeutics Corp)|CRGT - Wutah dodolan triwulanan|ATXI - Wutah pendapatan kuartal marang kuartal|BCLI: Wutah pendapatan kuartal marang kuartal|Cara Therapeutics (CARA) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Chromocell Therapeutics Corp (CHRO)|Wutah dodolan triwulanan ELYM|Tingkat wutah pendapatan sajrone kuartal intracellulartherapies.com ITCI|Wutah pendapatan kuartal marang kuartal Longboard Pharmaceuticals (LBPH)|MRNS (Marinus Pharmaceuticals) - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal NKGen NKGN|Wutah pendapatan triwulanan NeuroBo Pharmaceuticals Inc NRBO|SAGE: Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal Synaptogenix, Inc SNPX|TRVN: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Vigil Neuroscience (VIGL)|Wutah pendapatan kuartal marang kuartal Anew Medical, Inc.|CERE (Cerevel Therapeutics, Inc.) - Owah-owahan dodolan kuartal marang kuartal